Tennesse Health Science Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The U.S. Food and Drug Administration (FDA) has approved Mitsubishi Tanabe Pharma America's oral alternative to its own treatment for amyotrophic lateral sclerosis (ALS).

United statesSouth koreaLou gehrigTanabe pharma americaAtsushi fujimotoTulio bertoriniSarah silbiger gettyJourneymate support programDrug administrationUniversity of tennesse health science centerMitsubishi tanabe pharma development americaMitsubishi tanabe pharma americaTennesse health science centerDa approves oral version of established als drug radicava